Preliminary Rating Assigned In French RMBS Transaction FCT R&B BDDF PPI Dec 11

  • ID: 2030427
  • December 2011
  • Region: France
  • Standard & Poors
1 of 3

OVERVIEW We have assigned a preliminary 'AAA (sf)' rating to FCT R&B BDDF PPI's class A notes. Soci-t- G-n-rale originated the prime residential loans, granted to individuals or French property companies, to be securitized in this transaction. We have assigned this preliminary rating based on our criteria for counterparty and supporting party risk. However, these criteria are under review due to a proposed expansion. As a result of this review, our future counterparty criteria may differ from our current criteria. The criteria change may affect the ratings on all outstanding notes in this transaction. PARIS (Standard & Poor's) Dec. 9, 2011--Standard & Poor's Ratings Services today assigned its preliminary 'AAA (sf)' rating to FCT R&B BDDF PPI's (R&B BDDF PPI)...

Companies mentioned in this report are: FCT R&B BDDF PPI
Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3


Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.